NEW YORK (GenomeWeb News) — The Critical Path Institute has opened an office in Rockville, Md., the Tucson, Ariz.-based non-profit said this week.
C-Path moved into the offices in January, but made an official announcement on Monday.
C-Path was formed to support the US Food and Drug Administration, pharmaceutical companies, and academic institutions as the FDA tries to implement its Critical Path Initiative to accelerate the drug-development process.
C-Path Chief Scientific Officer Jeff Cossman told GenomeWeb Daily News today that it is important that C-Path have a presence near the FDA, the National Institutes of Health, the numerous biotech companies in the region, and the US Congress.
Cossman, who was former medical director of Gene Logic, said that “because the NIH is so under-funded these days” C-Path is working directly with Capitol Hill on legislation to help acquire extra federal funding for drug-development programs.
Cossman also said that being near many industry scientists makes it easier to recruit them to help pursue the aims of the Critical Path Initiative and to share scientific information.